Petition filed with FDA to withdraw Splenda from US market
A petition has been filed with the Food and Drug Administration (FDA) calling on the agency to revoke its approval of the sweetener Splenda, a move branded by manufacturer Tate & Lyle as a commercial conspiracy to damage its product's image.